Introduction
repeated äs often äs one may desire. aetiologies (1) . The extent and progress are usually assessed by histöpathological examination of biopsy The biosynthesis of collagen involves a number of specimens. Disadvantages of the histological exam^· enzymatic modifications, many of which are unique ination are that the actual rate of collagen synthesis to collagens and a few other proteins with collagenis difficult to assess and that biopsies cannot be like amino acid sequences (2-4). Two post-transla-tional enzymes can be estimated in serum in the form of immunoreactive prolyl hydroxylase protein and galactosylhydroxylysyl glucosyltransferase activity (5 -11) . Increased serum immunoreactive prolyl hydroxylase protein and serum galactosylhydroxylysyl glucosyltransferase activity have been reported in patients with various liver diseases (5 -12) . The two serum enzymes correlate significantly with the respective enzyme activities in liver biopsy specimens, which indicates that serum immunoreactive prolyl hydroxylase protein and serum galactosylhydroxylysyl glucosyltransferase activity may give useful Information on actual hepatic Collagen formation (10, 12, 13) .
A radioimmunoassay for the measurement of the serum amino-terminal propeptide of type III procollagen is now available (14) . The procollagens are biosynthetic precursors of various genetically distinct collagen types. They are processed to collagens by the enzymatic cleavage of their amino-and carboxyterminal extensions in the extracellular matrix (2, 4) . Increased serum aminoterminal propeptide of type III procollagen concentrations have been found especially in several liver diseases (14, 15) . No data have so far been reported concerning sickle cell disease, nör is it known whether the collagen laid down in liver, bone or other organs of patients with sickle cell disease (16) (17) (18) (19) can be detected by the measurement of serum immunoreactive prolyl hydroxylase protein, serum galactosylhydroxylysyl glucosyltransferase activity and serum aminoterminal propeptide of type III procollagen.
This communication reports our preliminary findings in the clinical application of radioimmunoassay techniques for separate determination of serum immunoreactive prolyl hydroxylase protein and serum aminoterminal propeptide of type III procollagen in patients with sickle cell disease. The serum galactosylhydroxylysyl glucosyltransferase activity was also measured in the same patients.
Patients and Methods
A total of twenty homozygous sickle cell patients, age 5-18 years, were examined. A reference control group of healthy Nigerians, sex-and age-matched, was also included in the investigation. Patients were first seen in the outpatient department of the University of Ife Teaching Hospitals, Ile-Ife. All the patients were asymptomatic at the time blood samples were taken for the assays; the only complaints were of moderate lassitude. Icterus was mild, but the liver was palpable in 11 or 55% of these patients. The diagnosis of sickle cell disease was based on clinical observation and confirmed by the finding of a haemoglobin SS pattern on cellulose acetate strip electrophoresis in the laboratory, after preliminary investigation had revealed very low haemoglobin and haematocrit values. All the control subjects had haemoglobin AA and no evidence of liver disease.
In both patients and controls, sera were separated after allowing the blood samples to coagulate for 2 h at room temperature and were stored frozen at -20 °C until assayed for serum immunoreactive prolyl hydroxylase protein and serum aminoterminal propeptide of type III procollagen total protein levels. All serum samples were either aliquots of samples taken for diagnostic purposes or were obtaine<^ with the pennission of the patients.
Serum immunoreactive prolyl hydroxylase protein was measured with a dkect radioimmunoassay based on the displacement of radioactively labelled human prolyl hydroxylase protein from its antibody by the non4abelled human enzyme protein and the precipitation of the enzyme protein-antibody complex by a ceUulose-bound second antibody (11, 12) . Pure human prolyl hydroxylase protein was used äs the Standard enzyme. The samples were assayed in düplicates and serum enzyme protein concentrations were expressed äs mg per liter. Serum aminoterminal propeptide of type III procollagen was measured using a radioimmunoassay kit (Behringwerke AG, Germany) based on the displacement of radioactively-labelled type III aminoterminal propeptide and the subsequent precipitation of the peptide-antibody complex by a second antibody (13) . Serum galactosylhydroxylysyl glucosyltransferase activity was measured by the method of Myllyla et al. (20) , äs modified for human serum samples (21) .
A Standard hospital laboratory method was used for the determination of serum alanine aminotransferase in 15 of our patients. It proved impossible to assay alanine aminotransferase in the remaining 5 patients äs the serum samples were too small.
The statistical significances of the differences between two means were calculated by Student*s t-test and the correlations were determined by linear regression analysis.
Results
The mean serum immunoreactive prolyl hydroxylase protein concentration for thie 20 control subjects was 1.16 ± 0.12 (SD) mg/l, the serum galactosylhydroxylysyl glucosyltransferase activity 0.33 ± 0.03 U/l and the serum aminoterminal propeptide of type III procollagen concentration 11.84 + 1.45 g/l. The corresponding upper normal limits defined äs the mean + 2 SD, were thus 1.40 mg/1, 0.39 U/l and 14.74 g/l.
Any individual values exceeding the upper normal limits were considered patholpgical ( fig. l a, b and c) . of type III procollagen values exceeding the upper normal limit ( fig. l b) . The data of the present investigation confirm the results of earlier morphological studies, which demonstrated collagen fibers and basement membranes in the livers and other organs of patients with sickle cell disease (16) (17) (18) (19) . All 11 patients who had elevated sefum aminoterminal propeptide of type III procollagen concentrations also had increased serum immunoreactive prolyl hydroxyl se protein and serum galactosylhydroxylysyl glucosyltransferase activity values.
The mean serum alanine aminotransferase in 15 patients with measured serum collagen enzymes and type III prpcollagen aminopropeptide was 15.53 ± 13.9 U/l. Grossly elevated values of alanine aminotransferase were observed in 3 of these 15 cases of sickle cell disease. All 3 patients had increased serum immunoreactive prolyl hydroxylase protein, serum galactosylhydroxylysyl glucosyltransferase activity and serum aminoterminal propeptide of type III procollagen values, Significant correlations were found between various pairs of values from the four tests, but not between the serum aminoterminal propeptide of type III procollagen and alanine aminotransferase test within the group of patients studied (tab. 1).
Discussion
The data reported here clearly demonstrate that serum immunoreactive prolyl hydroxylase protein, serum galactosylhydroxylysyl glucosyltransferase activity and serum aminoterminal propeptide of type III procollagen are elevated in cases of sickle cell disease. A high correlation was found between all three serum markers of collagen biosynthesis, within the group of patients studied, suggesting diffuse fibrogenesis. High correlations have previously been found between the three serum markers in patients with various liver diseases (6, 9, 11) , and are now demonstrated in sickle cell disease. Correlation of the two serum enzymes and serum aminoterminal propeptide of type III procollagen with tests of liver function have been reported earlier (10, 11, 13) , and here there were significant correlations between the two serum enzymes of collagen and serum alanine aminotransferase, but a very week correlation was found between alanine aminotransferase and serum aminoterminal propeptide of type III procollagen. It thus seemed likely that the two serum enzymes and serum aminoterminal propeptide of type III procollagen primarily reflect in sickle cell disease the actual changes in hepatic, bone or spieen collagen formation. Other liver enzyme assays such s aspartate aminotransferase, alkaline phosphatase and γ-glutamyl transferase may have been very helpful but these were not done due to lack of enough serum samples.
It may be noted that none of these three markers of collagen biosynthesis is entirely specific for liver involvement in sickle cell disease, so diffuse fibrotic changes in other organs, such s the spieen or bone of these patients, may also contribute to the elevated values of these enzymes of collagen synthesis and serum aminoterminal propeptide of type III procollagen.
